Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Prognostic Stratification and Importance of Follow-Up

Antonio Cannatà  1 , Davide Stolfo  1 , Marco Merlo  2 , Cosimo Carriere  1 , Gianfranco Sinagra  2
Gianfranco Sinagra  1 , Marco Merlo  1 , Bruno Pinamonti  1
, editors.
In: Dilated Cardiomyopathy: From Genetics to Clinical Management [Internet]. Cham (CH): Springer; 2019. Chapter 12.
.
Affiliations
Review

Prognostic Stratification and Importance of Follow-Up

Antonio Cannatà et al.

Excerpt

In the last decades, long-term survival of patients affected by dilated cardiomyopathy (DCM) has been markedly improved. The main milestones, such as the early diagnosis and the systematic follow-up, the proper etiological characterization at the onset of the disease, and a multidisciplinary approach to the patients together with the optimal medical and device treatment and the rigorous tailored follow-up, accompanied these prognostic improvements. However, DCM still remains the most common cause of heart transplantation and one of the leading causes of cardiac death in the western world. Therefore, proper prognostic stratification and systematic follow-up are the cornerstones to optimize medical management and improve outcomes of patients with DCM.

PubMed Disclaimer

References

    1. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10(9):531–47. https://doi.org/10.1038/nrcardio.2013.105. - DOI - PubMed
    1. Merlo M, Cannata A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20(2):228–39. https://doi.org/10.1002/ejhf.1103. - DOI - PubMed
    1. Merlo M, Cannata A, Vitagliano A, Zambon E, Lardieri G, Sinagra G. Clinical management of dilated cardiomyopathy: current knowledge and future perspectives. Expert Rev Cardiovasc Ther. 2016;14(2):137–40. https://doi.org/10.1586/14779072.2016.1125292. - DOI - PubMed
    1. Merlo M, Gentile P, Naso P, Sinagra G. The natural history of dilated cardiomyopathy: how has it changed? J Cardiovasc Med (Hagerstown). 2017;18(Suppl 1):e161–e5. https://doi.org/10.2459/JCM.0000000000000459. - DOI - PubMed
    1. Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014;16(3):317–24. https://doi.org/10.1002/ejhf.16. - DOI - PubMed